Enhancing survival outcomes in the management of patients with higher-risk myelodysplastic syndromes

scientific article published on October 2009

Enhancing survival outcomes in the management of patients with higher-risk myelodysplastic syndromes is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1177/107327480901604S03
P698PubMed publication ID20010512

P50authorEvelyn R Hermes-DeSantisQ41205981
P2093author name stringSteven D Gore
P304page(s)2-10
P577publication date2009-10-01
P1433published inCancer ControlQ15724614
P1476titleEnhancing survival outcomes in the management of patients with higher-risk myelodysplastic syndromes
P478volume16 Suppl

Reverse relations

cites work (P2860)
Q41471081A multivariate analysis of the relationship between response and survival among patients with higher-risk myelodysplastic syndromes treated within azacitidine or conventional care regimens in the randomized AZA-001 trial
Q38737783Arsenic trioxide and triptolide synergistically induce apoptosis in the SKM‑1 human myelodysplastic syndrome cell line
Q33706374BIIB021, an Hsp90 inhibitor, effectively kills a myelodysplastic syndrome cell line via the activation of caspases and inhibition of PI3K/Akt and NF-κB pathway proteins
Q34764504Biology, risk stratification, and therapy of pediatric acute leukemias: an update
Q26865904Emerging therapeutic biomarkers in endometrial cancer
Q33972354Genomic DNA hypomethylation by histone deacetylase inhibition implicates DNMT1 nuclear dynamics
Q26801573Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?
Q38248180Stopping higher-risk myelodysplastic syndrome in its tracks

Search more.